Moreover, the study of Lin et al. [32] introduces a potential therapeutic strategy for glioblastoma through oridonin-induced downregulation of RANGAP1, leading to RNA accumulation and subsequent glioma cell apoptosis. Here, RANGAP1 is linked to central nervous system cancer.